|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Company details: Hospira, Inc.
Group companies: Hospira, Inc.
| Name | Category and Sector |
|---|---|
Hospira UK Ltd.
 Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | +1.72% | +38.30% | +104.56% | 1,060B | |
| -0.76% | -0.84% | +35.21% | +61.78% | 623B | |
| +0.39% | +4.81% | +17.81% | +82.70% | 480B | |
| -0.29% | -0.99% | +64.79% | +36.25% | 352B | |
| -2.03% | +1.03% | +22.25% | +42.16% | 345B | |
| -1.92% | -1.87% | +11.94% | +33.20% | 274B | |
| -2.36% | -3.16% | -6.95% | +8.68% | 249B | |
| -1.37% | +0.04% | +38.29% | +50.05% | 223B | |
| +0.17% | -0.27% | +24.40% | +95.98% | 182B | |
| Average | -1.43% | -0.48% | +27.34% | +57.26% | 420.89B | |
| Weighted average by Cap. | -1.33% | +0.04% | +30.65% | +67.62% |
- Stock Market
- Stocks
- Stock
- Company Hospira, Inc.
Select your edition
All financial news and data tailored to specific country editions
